Creator of Ivermectin To Release “COVID Pill” With Seemingly Similar Mechanisms

Creator of Ivermectin To Release “COVID Pill” With Seemingly Similar Mechanisms


Merck, the company known for inventing the lifesaving & Nobel Prize-winning drug ivermectin, and Ridgeback Biotherapeutics said they’ve developed a drug that reduces the risk of hospitalization or death for about half of patients with mild or moderate cases of Covid, CNBC reported on Friday.

The drug, molnupiravir, is administered orally in the form of a pill and reportedly works by inhibiting the replication of the coronavirus inside the body. It also appears to share similar mechanisms with ivermectin when fighting COVID-19.

Trending: BREAKING: Biden Regime Accused of “Child Trafficking”

According to a press release from Merck, Molnupiravir “inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19.” Meanwhile, a scientific study

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend